Ebola Outbreaks in Africa Trigger Global Health Emergency, U.S. Travel Warnings
via HealthDayMONDAY, May 18, 2026 — The World Health Organization (WHO) has declared an ebola outbreak in the Democratic Republic of Congo (DRC) an international public health emergency.
The declaration means there is a high risk of cross-border spread and international cooperation will likely be needed to contain the threat, StatNews reported.
The United States withdrew from WHO under the Trump administration earlier this year, which StatNews noted may impact the country’s access to key infectious disease intelligence.
While warning that the outbreak could potentially be "much larger" than is now known, WHO said it does not yet meet the criteria of a pandemic.
As of Sunday, there were reports of 10 confirmed cases and 336 suspected ones, including 88 deaths in DRC, as well as two confirmed cases including one death in Uganda, according to the U.S. Centers for Disease Control and Prevention (CDC).
At least six Americans in the DRC are believed to have high-risk exposures, the BBC reported, and one is believed to have developed symptoms.
The CDC’s webpage says the overall risk to the American public and travelers remains low.
The CDC is supporting the "safe withdrawal of a small number of Americans who are directly affected in outbreak areas," the website adds.
The U.S. government is looking to arrange safe transport of these Americans to a safe quarantine location.
At a news conference Sunday, the agency would not answer any direct questions about the affected Americans, according to the BBC.
The current strain of Ebola is caused by the Bundibugyo virus, one of the four types of orthoebolaviruses that cause Ebola disease in people, according to the CDC. There are currently no vaccines or drugs for the Bundibugyo virus.
Patients have reportedly experienced classic Ebola disease symptoms like fever, headache, vomiting, severe weakness, abdominal pain, nosebleeds and vomiting blood, the CDC said.
Most of the Ebola cases in the DRC have been in people between 20 and 39 years old, with two-thirds in female patients, according to the CDC.
While noting that the risk to the American public is "extremely low," CDC said in a statement that it will continue to "evaluate the evolving situation and may adjust public health measures as additional information becomes available."
The U.S. has issued a Level Four advisory – its most severe level – warning against travel to the Democratic Republic of Congo.
The U.S. Department of Homeland Security has implemented enhanced travel screening, entry restrictions and public health measures to prevent Ebola virus disease from entering the United States.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-05-19 02:40
Read more
- Boehringer Ingelheim’s Novel Glucagon/GLP-1 Dual Agonist Survodutide Achieved Significant Weight Loss and Meaningful Metabolic Improvement in Phase III Trial
- Lilly's Jaypirca (pirtobrutinib) Significantly Extended Progression-Free Survival When Added to a Venetoclax Time-Limited Regimen in Patients with Previously Treated CLL/SLL
- First Gene Therapy for Genetic Hearing Loss, Otarmeni, Gains FDA Approval
- FDA Approves Inqovi in Combination with Venetoclax, the First All-Oral Combination Treatment for Patients with Acute Myeloid Leukemia Who Are Ineligible for Intensive Induction Chemotherapy
- VR Training Helps Autistic People Navigate Police Encounters
- Service Dogs Perform Tasks Akin To Human Caregivers, Researchers Say
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions